Literature DB >> 27063351

Adoptive Transfer of Tracer-Alloreactive CD4+ T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft.

M L Miller1, J Chen2, M D Daniels2, M G McKeague1, Y Wang1, D Yin2, V Vu2, A S Chong2, M-L Alegre1.   

Abstract

T cell receptor transgenic (TCR-Tg) T cells are often used as tracer populations of antigen-specific responses to extrapolate findings to endogenous T cells. The extent to which TCR-Tg T cells behave purely as tracer cells or modify the endogenous immune response is not clear. To test the impact of TCR-Tg T cell transfer on endogenous alloimmunity, recipient mice were seeded with CD4+ or CD8+ TCR-Tg or polyclonal T cells at the time of cardiac allograft transplantation. Only CD4+ TCR-Tg T cells accelerated rejection and, unexpectedly, led to a dose-dependent decrease in both transferred and endogenous T cells infiltrating the graft. In contrast, recipients of CD4+ TCR-Tg T cells exhibited enhanced endogenous donor-specific CD8+ T cell activation in the spleen and accelerated alloantibody production. Introduction of CD4+ TCR-Tg T cells also perturbed the intragraft accumulation of innate cell populations. Transferred CD4+ TCR-Tg T cells alter many aspects of endogenous alloimmunity, suggesting that caution should be used when interpreting experiments using these adoptively transferred cells because the overall nature of allograft rejection may be altered. These results also may have implications for adoptive CD4+ T cell immunotherapy in tumor and infectious clinical settings because cell infusion may have additional effects on natural immune responses. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; alloantibody; alloantigen; animal models: murine; basic (laboratory) research/science; heart transplantation/cardiology; immunobiology; rejection: acute

Mesh:

Substances:

Year:  2016        PMID: 27063351      PMCID: PMC5065388          DOI: 10.1111/ajt.13821

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  27 in total

1.  Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide.

Authors:  Kazuhito Honjo; Xiao Yan Xu; Judith A Kapp; R Pat Bucy
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

2.  Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.

Authors:  Vladimir P Badovinac; Jodie S Haring; John T Harty
Journal:  Immunity       Date:  2007-06-07       Impact factor: 31.745

3.  The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.

Authors:  Gerald J Berry; Margaret M Burke; Claus Andersen; Patrick Bruneval; Marny Fedrigo; Michael C Fishbein; Martin Goddard; Elizabeth H Hammond; Ornella Leone; Charles Marboe; Dylan Miller; Desley Neil; Doris Rassl; Monica P Revelo; Alexandra Rice; E Rene Rodriguez; Susan Stewart; Carmela D Tan; Gayle L Winters; Lori West; Mandeep R Mehra; Annalisa Angelini
Journal:  J Heart Lung Transplant       Date:  2013-12       Impact factor: 10.247

4.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.

Authors:  Stefani Spranger; Riyue Bao; Thomas F Gajewski
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

5.  Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig.

Authors:  J Chen; H Yin; J Xu; Q Wang; K L Edelblum; R Sciammas; A S Chong
Journal:  Am J Transplant       Date:  2013-07-15       Impact factor: 8.086

6.  CD4+ but not CD8+ cells are essential for allorejection.

Authors:  N R Krieger; D P Yin; C G Fathman
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  T helper 17 cells promote cytotoxic T cell activation in tumor immunity.

Authors:  Natalia Martin-Orozco; Pawel Muranski; Yeonseok Chung; Xuexian O Yang; Tomohide Yamazaki; Sijie Lu; Patrick Hwu; Nicholas P Restifo; Willem W Overwijk; Chen Dong
Journal:  Immunity       Date:  2009-10-29       Impact factor: 31.745

8.  Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients.

Authors:  Jianjun Chen; Qiang Wang; Dengping Yin; Vinh Vu; Roger Sciammas; Anita S Chong
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

9.  Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.

Authors:  M B Ezzelarab; H Zhang; H Guo; L Lu; A F Zahorchak; R W Wiseman; M A Nalesnik; J K Bhama; D K C Cooper; A W Thomson
Journal:  Am J Transplant       Date:  2016-03-17       Impact factor: 8.086

10.  In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.

Authors:  E Ingulli; A Mondino; A Khoruts; M K Jenkins
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

View more
  7 in total

1.  Selective CD28 Blockade Results in Superior Inhibition of Donor-Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4-Ig.

Authors:  I R Badell; G M La Muraglia; D Liu; M E Wagener; G Ding; M L Ford
Journal:  Am J Transplant       Date:  2017-08-14       Impact factor: 8.086

Review 2.  Antigen Presentation in Transplantation.

Authors:  Maria-Luisa Alegre; Fadi G Lakkis; Adrian E Morelli
Journal:  Trends Immunol       Date:  2016-10-12       Impact factor: 16.687

3.  Resilience of T cell-intrinsic dysfunction in transplantation tolerance.

Authors:  Michelle L Miller; Christine M McIntosh; Ying Wang; Luqiu Chen; Peter Wang; Yuk Man Lei; Melvin D Daniels; Elyse Watkins; Carolina Mora Solano; Anita S Chong; Maria-Luisa Alegre
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-04       Impact factor: 11.205

4.  CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.

Authors:  Stella H Khiew; Jinghui Yang; James S Young; Jianjun Chen; Qiang Wang; Dengping Yin; Vinh Vu; Michelle L Miller; Roger Sciammas; Maria-Luisa Alegre; Anita S Chong
Journal:  JCI Insight       Date:  2017-05-04

Review 5.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

6.  Long-term survival in non-human primates of stem cell-derived, MHC-unmatched corneal epithelial cell sheets.

Authors:  Yu Yoshinaga; Takeshi Soma; Shohei Azuma; Kazuichi Maruyama; Yoshiko Hashikawa; Tomohiko Katayama; Yuzuru Sasamoto; Hiroshi Takayanagi; Naoki Hosen; Takashi Shiina; Kazumasa Ogasawara; Ryuhei Hayashi; Kohji Nishida
Journal:  Stem Cell Reports       Date:  2022-06-23       Impact factor: 7.294

7.  Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and Tolerance.

Authors:  Michelle L Miller; Christine M McIntosh; Jason B Williams; Ying Wang; Maile K Hollinger; Noel J Isaad; James J Moon; Thomas F Gajewski; Anita S Chong; Maria-Luisa Alegre
Journal:  Cell Rep       Date:  2018-08-21       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.